Table 1.
Initial Dosing | 1st Year Cost of Therapy | Maintenance Dosing | Annual Cost | Escalated Dosing | Annual Cost | |
---|---|---|---|---|---|---|
Etanercept | 50 mg twice weekly for 3 months, then 50 mg weekly | $67,386 | 50 mg weekly | $53,909 | 50 mg twice weekly | $107,818 |
Adalimumab | 80 mg once, then 40 mg every other week | $58,045 | 40 mg every other week | $53,899 | 40 mg weekly | $107,798 |
Ustekinumab | ≤ 100 kg: 45 mg at weeks 0 & 4, then every 12 weeks | $58,966 | 45 mg every 12 weeks | $39,311 | 90 mg every 12 weeks | $78,622 |
> 100 kg: 90 mg at Week 0 and Week 4, then every 12 weeks |
$117,933 | 90 mg every 12 weeks | $78,622 | 90 mg every 8 weeks | $117,933 | |
Secukinumab | 300 mg weekly for 5 weeks, then 300 mg every 4 weeks | $70,195 | 300 mg every 4 weeks | $57,033 | ||
Option to decrease to 150 mg every 4 weeks | ⁎$28,517 | |||||
Ixekizumab | 160 mg once, then 80 mg every 2 weeks for 12 weeks, then 80 mg every 4 weeks | $83,714 | 80 mg every 4 weeks | $59,093 | 80 mg every 2 weeks | $118,185 |
Notes: Prices reflect average wholesale prices and may not include negotiated rebates or other discounts. Actual patient copays may be discordant with health system costs.
The 150 mg package is the same price as the 300 mg package, but the 300 mg package could theoretically be split into two 150 mg doses to decrease costs.